KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Shares Outstanding (2017 - 2025)

Elanco Animal Health's Shares Outstanding history spans 6 years, with the latest figure at $474.1 million for Q2 2022.

  • For Q2 2022, Shares Outstanding changed 0.23% year-over-year to $474.1 million; the TTM value through Jun 2022 reached $474.1 million, changed 0.23%, while the annual FY2021 figure was $473.1 million, 0.23% changed from the prior year.
  • Shares Outstanding for Q2 2022 was $474.1 million at Elanco Animal Health, roughly flat from $474.1 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $474.1 million in Q1 2022 and bottomed at $293.3 million in Q1 2018.
  • The 5-year median for Shares Outstanding is $399.0 million (2020), against an average of $409.8 million.
  • The largest annual shift saw Shares Outstanding increased 26.51% in 2020 before it increased 0.23% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $365.6 million in 2018, then increased by 2.02% to $373.0 million in 2019, then rose by 26.51% to $471.9 million in 2020, then increased by 0.25% to $473.1 million in 2021, then grew by 0.21% to $474.1 million in 2022.
  • Per Business Quant, the three most recent readings for ELAN's Shares Outstanding are $474.1 million (Q2 2022), $474.1 million (Q1 2022), and $473.1 million (Q4 2021).